The Cleveland Clinic analysis found that many patients who stopped GLP-1 therapy later restarted, sometimes with the same medication, sometimes switching to an alternative
Ozempic and Wegovy are proven, FDA-approved, and available today
These medications activate GLP-1 receptors (and sometimes GIP receptors), helping you feel fuller for a longer period, reducing cravings, and improving metabolic function
Both semaglutide and tirzepatide are FDA-approved for use alongside diet and exercise meaning movement should be part of the plan
adults meet FDA eligibility for semaglutide using nationally representative data, this is higher among Black (57 %) and Hispanic (55 %) adults [231]
Birte (1874-1943) was the fourth woman in Denmark to receive an advanced medical degree in 1914